Stuttgart
05.12.25 | 07:49
0,016 Euro
+933,33 % +0,014
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,000 | 0,013 | 12:16 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.11. | Update on Episurf Medical's MTP implant | 2 | Cision News | ||
| 02.11. | Board Member Resigns from the Board of Episurf Medical | 2 | Cision News | ||
| 24.10. | Episurf Medical AB: Interim Report 1 January - 30 September 2025 | 111 | GlobeNewswire (Europe) | Strong US growth in gross-order intake and customer base
Significantly improved financial results
Continued focus on regulatory pathway for MTP-implant
"This is my first CEO statement as CEO... ► Artikel lesen | |
| 17.10. | EPISURF MEDICAL AB: Scientific article on Episealer Knee with up to 10 years' follow-up published | 3 | Cision News | ||
| 12.10. | Board Member Resigns from the Board of Episurf Medical | 3 | Cision News | ||
| EPISURF MEDICAL Aktie jetzt für 0€ handeln | |||||
| 30.09. | Change in number of shares and votes in Episurf Medical | 2 | Cision News | ||
| 16.09. | Episurf Medical AB: New Chief Executive Officer at Episurf Medical | 306 | GlobeNewswire (Europe) | Episurf Medical (Nasdaq: EPIS B) today announces that, at his own request, Pål Ryfors will step down as Chief Executive Officer of Episurf Medical. The Board of Directors has appointed Katarina Flodström... ► Artikel lesen | |
| 01.09. | EPISURF MEDICAL AB: Episealer included in the Swedish Knee Arthroplasty Register 2025 | 4 | Cision News | ||
| 29.08. | Episurf Medical AB changes liquidity provider to Mangold Fondkommission AB | 2 | Cision News | ||
| 28.08. | Episurf Medical resolves on an issue of units to guarantors in connection with the completed rights issue | 1 | Cision News | ||
| 25.08. | Episurf Medical announces final outcome of the rights issue | 1 | Cision News | ||
| 22.08. | EPISURF MEDICAL AB: Preliminary outcome indicates significantly oversubscribed rights issue | 1 | Cision News | ||
| 20.08. | Episurf Medical announces interview with CEO | 1 | Cision News | ||
| 07.08. | Listing of units rights and paid subscription units of Episurf Medical AB | 306 | GlobeNewswire | With effect from August 08, 2025, the units rights of Episurf Medical AB will be traded on the list for Equity rights. Trading will continue up until and including August 19, 2025.
Instrument:
Units... ► Artikel lesen | |
| 05.08. | Episurf Medical publishes prospectus in connection with the company's rights issue of units | 2 | Cision News | ||
| 04.08. | Episurf Medical AB: Summary from the Extraordinary General Meeting of Episurf Medical AB (publ) | 216 | GlobeNewswire (Europe) | Episurf Medical AB (publ) held an Extraordinary General Meeting in Stockholm today 4 August 2025 at which it was resolved, among other things, to approve the Board of Directors' resolution on a rights... ► Artikel lesen | |
| 04.08. | XFRA CAPITAL ADJUSTMENT INFORMATION - 04.08.2025 | 586 | Xetra Newsboard | Das Instrument 5QO SE0016829824 QLUCORE AB EQUITY wird cum Kapitalmassnahme gehandelt am 04.08.2025 und ex Kapitalmassnahme am 05.08.2025 The instrument 5QO SE0016829824 QLUCORE AB EQUITY is traded... ► Artikel lesen | |
| 01.08. | The Swedish Securities Council grants exemption from the obligation to submit a mandatory offer in connection with Episurf Medical's rights issue of units | 2 | Cision News | ||
| 11.07. | Episurf Medical AB: Interim Report 1 January - 30 June 2025 | 187 | GlobeNewswire (Europe) | • Improved results of SEK 7.0m adjusted for re-structuring provision of SEK 3.1m, with additional cost savings identified
• More than 100% growth in the U.S. customer base and continued expansion of... ► Artikel lesen | |
| 03.07. | Notice of Extraordinary General Meeting of Episurf Medical AB (publ) | 2 | Cision News |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| IMUNON | 3,420 | -1,72 % | Imunon, Inc.: IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update | R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advanced... ► Artikel lesen | |
| ELECTROCORE | 4,080 | 0,00 % | electroCore, Inc.: electroCore Announces Third Quarter 2025 Financial Results | Net sales of $8.7 million increased 33% vs. Q3 2024; YTD net sales of $22.8 million increased 26% vs. first nine months of 2024 Cash, cash equivalents, restricted cash, and marketable securities ("Total... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 35,430 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,400 | 0,00 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| PROGYNY | 24,150 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| GENEDX | 161,95 | +0,98 % | Cathie Wood's ARK sells Iridium, buys GeneDx and WeRide stock | ||
| BETA BIONICS | 30,000 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| CASTLE BIOSCIENCES | 39,620 | 0,00 % | Castle Biosciences, Inc.: New Data Confirms Performance of DecisionDx-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity | FRIENDSWOOD, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data... ► Artikel lesen | |
| NUTEX HEALTH | 156,79 | 0,00 % | Nutex Health extends share repurchase plan | ||
| SIEMENS HEALTHINEERS | 43,110 | +0,98 % | EQS-DD: Siemens Healthineers AG: Elisabeth Staudinger-Leibrecht, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
28.11.2025 / 17:23... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,590 | +1,45 % | Neue 3,250%-Anleihe von Fresenius Medical Care | Stuttgart (www.anleihencheck.de) - Fresenius Medical Care (ISIN DE0005785802/ WKN 578580) hat eine Unternehmensanleihe (ISIN XS3233499089/ WKN A460DH) mit einem Volumen von bis zu 500 Millionen Euro... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,160 | 0,00 % | BMO Capital Maintains Bullish 12%+ BrightSpring EBITDA Growth Outlook on Drug Contract Wins, Generic Conversions | ||
| FRESENIUS | 48,210 | +0,42 % | EQS-News: mAbxience und HP treiben den Einsatz künstlicher Intelligenz bei der Bioproduktion und der Entwicklung von Biosimilars voran | EQS-News: mAbxience
/ Schlagwort(e): Joint Venture/Produkteinführung
mAbxience und HP treiben den Einsatz künstlicher Intelligenz bei der Bioproduktion und der Entwicklung von... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 24,500 | -5,11 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Preliminary Second Quarter Fiscal 2026 Financial Results | KIRKLAND, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported preliminary financial... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,000 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen |
Das Unternehmen EPISURF MEDICAL AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +933,33 % bei einem Aktienkurs von 0,016 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EPISURF MEDICAL AB finden Sie auf Wallstreet Online.